SCHEMBL6322843

SCHEMBL6322843

CC(=O)OCOC(CCC(Cc1cccc(F)c1)NC(=O)c1cc2ccccc2s1)(O[PH2]=O)OC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 9/20 0.56
OPRM1 P35372 2/20 0.40
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
CIT O14578 1/20 0.37
ROCK2 O75116 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKACA P17612 1/20 0.37
PRKACB P22694 1/20 0.37
AKT1 P31749 1/20 0.37
AKT2 P31751 1/20 0.37
ROCK1 Q13464 1/20 0.37
PKN1 Q16512 1/20 0.37
PRKD2 Q9BZL6 1/20 0.37
AKT3 Q9Y243 1/20 0.37
KLKB1 P03952 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
CLK1 P49759 1/20 0.34
CLK2 P49760 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321238 0.90 PIN1 (0.55) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL6326404 0.87 PIN1 (0.59) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL6322839 0.79 PIN1 (0.66) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL6325242 0.78 PIN1 (0.76) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL6326648 0.75 PIN1 (0.76) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL6326102 0.73 PIN1 (0.57) PIN1
SCHEMBL6269848 0.71 PIN1 (0.79) PIN1OPRM1TAS1R3TAS1R1CIT
SCHEMBL16550476 0.71 PIN1 (1.00) PIN1OPRM1TAS1R3TAS1R1HDAC2
SCHEMBL16550475 0.71 PIN1 (1.00) PIN1OPRM1TAS1R3TAS1R1HDAC2
SCHEMBL6331037 0.71 PIN1 (1.00) PIN1OPRM1TAS1R3TAS1R1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250742-A1 Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1) PFIZER INC. 2005-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250742-A1 Phosphate/sulfate ester compounds and pharmaceutical composition for inhibiting protein interacting NIMA (PIN1) PIN1, PSTPIP2, NIM1K PIN1 1/4885OPRM1 3859/4885TAS1R3 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.